Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban
Aim. Thrombin not only plays a central role in thrombus formation and platelet activation, but also in induction of inflammatory processes. Activated factor X (FXa) is traditionally known as an important player in the coagulation cascade responsible for thrombin generation. We assessed the hypothesi...
Saved in:
Main Authors: | Qianxing Zhou (Author), Florian Bea (Author), Michael Preusch (Author), Hongjie Wang (Author), Berend Isermann (Author), Khurrum Shahzad (Author), Hugo A. Katus (Author), Erwin Blessing (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis
by: Preusch MR, et al.
Published: (2016) -
Rhizoma coptidis Inhibits LPS-Induced MCP-1/CCL2 Production in Murine Macrophages via an AP-1 and NF𝜅B-Dependent Pathway
by: Andrew Remppis, et al.
Published: (2010) -
Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe-/- mice
by: Julia Leipner, et al.
Published: (2021) -
Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis
by: Sievers P, et al.
Published: (2015) -
Chromogenic anti-Xa test: the ratio between heparin activity units and concentration of apixaban and rivaroxaban
by: E. V. Titaeva, et al.
Published: (2020)